Imaging in retinal vascular disease: A review.
Häner NU, Dysli C, Munk MR.
Clin Exp Ophthalmol. 2023 Apr;51(3):217-228. doi: 10.1111/ceo.14203. Epub 2023 Jan 13.
Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.
Youngblood H, Robinson R, Sharma A, Sharma S.
Int J Mol Sci. 2019 Sep 25;20(19):4755. doi: 10.3390/ijms20194755.
Retinal vascular disease.
Feman SS.
Am Fam Physician. 1974 Oct;10(4):141-52.
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.
Wang X, Wang T, Lam E, Alvarez D, Sun Y.
Int J Mol Sci. 2023 Jul 28;24(15):12090. doi: 10.3390/ijms241512090.
Red blood cells in retinal vascular disorders.
Agrawal R, Sherwood J, Chhablani J, Ricchariya A, Kim S, Jones PH, Balabani S, Shima D.
Blood Cells Mol Dis. 2016 Jan;56(1):53-61. doi: 10.1016/j.bcmd.2015.10.003. Epub 2015 Oct 26.
Assessment of retinal vascular calibres as a biomarker of disease activity in birdshot chorioretinopathy.
Agrawal R, Joachim N, Li LJ, Lee J, Agarwal A, Sim DA, Keane PA, Liew G, Pavesio CE.
Acta Ophthalmol. 2017 Mar;95(2):e113-e118. doi: 10.1111/aos.13156. Epub 2016 Aug 6.
Retinal biomarkers provide "insight" into cortical pharmacology and disease.
Nguyen CTO, Hui F, Charng J, Velaedan S, van Koeverden AK, Lim JKH, He Z, Wong VHY, Vingrys AJ, Bui BV, Ivarsson M.
Pharmacol Ther. 2017 Jul;175:151-177. doi: 10.1016/j.pharmthera.2017.02.009. Epub 2017 Feb 5.
All-trans-Retinaldehyde Contributes to Retinal Vascular Permeability in Ischemia Reperfusion.
Dreffs A, Lin CM, Liu X, Shanmugam S, Abcouwer SF, Kern TS, Antonetti DA.
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):8. doi: 10.1167/iovs.61.6.8.
A review of diseases of the retina for neurologists.
Gregory-Evans K.
Handb Clin Neurol. 2021;178:1-11. doi: 10.1016/B978-0-12-821377-3.00001-5.
Neuroretinitis.
Ray S, Gragoudas E.
Int Ophthalmol Clin. 2001 Winter;41(1):83-102. doi: 10.1097/00004397-200101000-00009.
